AT343296B - Verfahren zur herstellung des neuen 3-oxo-17beta-n-amyloxy-ostra-4,9,11-triens - Google Patents

Verfahren zur herstellung des neuen 3-oxo-17beta-n-amyloxy-ostra-4,9,11-triens

Info

Publication number
AT343296B
AT343296B AT150775A AT150775A AT343296B AT 343296 B AT343296 B AT 343296B AT 150775 A AT150775 A AT 150775A AT 150775 A AT150775 A AT 150775A AT 343296 B AT343296 B AT 343296B
Authority
AT
Austria
Prior art keywords
triens
ostra
17beta
amyloxy
oxo
Prior art date
Application number
AT150775A
Other languages
English (en)
Other versions
ATA150775A (de
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ATA150775A publication Critical patent/ATA150775A/de
Application granted granted Critical
Publication of AT343296B publication Critical patent/AT343296B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0077Ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT150775A 1974-09-20 1975-02-27 Verfahren zur herstellung des neuen 3-oxo-17beta-n-amyloxy-ostra-4,9,11-triens AT343296B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7431840A FR2285138A1 (fr) 1974-09-20 1974-09-20 Nouveau derive steroide trienique, son procede de preparation et son application comme medicament

Publications (2)

Publication Number Publication Date
ATA150775A ATA150775A (de) 1977-09-15
AT343296B true AT343296B (de) 1978-05-26

Family

ID=9143293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT150775A AT343296B (de) 1974-09-20 1975-02-27 Verfahren zur herstellung des neuen 3-oxo-17beta-n-amyloxy-ostra-4,9,11-triens

Country Status (23)

Country Link
US (1) US4105761A (de)
JP (1) JPS5813560B2 (de)
AR (1) AR203898A1 (de)
AT (1) AT343296B (de)
BE (1) BE826077A (de)
CA (1) CA1027930A (de)
CH (1) CH595398A5 (de)
DD (1) DD118872A5 (de)
DE (1) DE2508775C2 (de)
DK (1) DK134408B (de)
ES (1) ES435087A1 (de)
FR (1) FR2285138A1 (de)
GB (1) GB1457396A (de)
HU (1) HU169763B (de)
IE (1) IE40943B1 (de)
IL (1) IL46705A (de)
LU (1) LU71928A1 (de)
NL (1) NL7502319A (de)
OA (1) OA04963A (de)
PL (1) PL94852B1 (de)
SE (1) SE407410B (de)
SU (1) SU555857A3 (de)
ZA (1) ZA751097B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL51468A (en) * 1976-02-23 1981-01-30 Sparamedica Ag 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1491586A (fr) * 1965-07-30 1967-08-11 Ciba Geigy Procédé de préparation de delta4, 9, 11-triènes de la série du 19-nor-androstane
CH488682A (de) * 1965-07-30 1970-04-15 Ciba Geigy Verfahren zur Herstellung von 4,9,11-Trienen der 19-Nor-androstanreihe
FR5301M (de) * 1966-01-21 1967-08-16
US3629244A (en) * 1966-01-21 1971-12-21 Roussel Uclaf 17beta-ethers of delta 4 9 11-gonatrienes and compositions containing them
FR6556M (de) * 1967-06-20 1968-12-23

Also Published As

Publication number Publication date
SE407410B (sv) 1979-03-26
IE40943L (en) 1976-03-20
JPS5156440A (de) 1976-05-18
CA1027930A (en) 1978-03-14
ES435087A1 (es) 1976-12-16
DK79675A (de) 1976-03-21
DD118872A5 (de) 1976-03-20
IL46705A0 (en) 1975-04-25
DE2508775A1 (de) 1976-04-08
FR2285138A1 (fr) 1976-04-16
HU169763B (de) 1977-02-28
JPS5813560B2 (ja) 1983-03-14
ATA150775A (de) 1977-09-15
GB1457396A (en) 1976-12-01
SE7502232L (sv) 1976-03-22
US4105761A (en) 1978-08-08
DK134408B (da) 1976-11-01
DE2508775C2 (de) 1984-04-12
SU555857A3 (ru) 1977-04-25
OA04963A (fr) 1980-10-31
PL94852B1 (de) 1977-09-30
DK134408C (de) 1977-04-04
CH595398A5 (de) 1978-02-15
AU7864975A (en) 1976-09-02
AR203898A1 (es) 1975-10-31
ZA751097B (en) 1976-01-28
BE826077A (fr) 1975-08-27
IE40943B1 (en) 1979-09-12
NL7502319A (nl) 1976-03-23
LU71928A1 (de) 1975-12-09
IL46705A (en) 1978-12-17
FR2285138B1 (de) 1978-07-21

Similar Documents

Publication Publication Date Title
AT341664B (de) Verfahren zur herstellung des neuen antibioticums thienamycin
AT347582B (de) Verfahren zur herstellung des neuen 4'- deoxydaunomycins
AT360663B (de) Verfahren zur herstellung von neuen 6,7- -benzomorphanen
AT342026B (de) Verfahren zur herstellung von neuen d,l-n-acyltyrosinamiden
AT342045B (de) Verfahren zur herstellung von neuen 1,1-diaryl-1-oxadiazolalkylaminen
AT354434B (de) Verfahren zur herstellung von neuen 1,4- diphenyl-3-pyrazolin-5-onen
AT348142B (de) Verfahren zur herstellung von neuen 8,8- disubstituierten 6-methylergolinen
AT341540B (de) Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen
AT351689B (de) Verfahren zur herstellung des neuen l- pyroglutamyl-l-prolinamids
AT342023B (de) Verfahren zur herstellung von neuen 2,4-disulfonamidoanilinverbindungen
AT360529B (de) Verfahren zur herstellung von neuen 1,2,3- triazolderivaten
AT341493B (de) Verfahren zur herstellung des neuen 3,7-dimethyl-3-acetoxy-6-octensaurenitrils
AT343615B (de) Verfahren zur herstellung des neuen 2-chlor -1,2,2- trifluorathyl - difluormethylathers
AT344923B (de) Verfahren zur herstellung des neuen vincamin-2-ketoglutarates
AT341492B (de) Verfahren zur herstellung des neuen 3,7-dimethyl-3-hydroxy-6-octensaurenitrils
AT343296B (de) Verfahren zur herstellung des neuen 3-oxo-17beta-n-amyloxy-ostra-4,9,11-triens
AT345479B (de) Verfahren zur herstellung des neuen 3beta- (4'-oxo-alfa-l-rhamnosyl) -14beta-hydroxy-bufa-4,20,22-trienolids
AT351014B (de) Verfahren zur herstellung des neuen 2-methyl- 4-trifluormethylanilins
AT339904B (de) Verfahren zur herstellung von neuen 3,6-diamino- 3,4 -dihydropyridonen-2
AT341669B (de) Verfahren zur herstellung von neuen 3,4-dicarboxycephalosporinen
ATA652577A (de) Verfahren zur herstellung des neuen 11- -bromvincamins
AT335444B (de) Verfahren zur herstellung von neuen 6,7-dichlor-1-indanonverbindungen
AT352719B (de) Verfahren zur herstellung des neuen 2,6,6- trimethyl-2-cyanmethyl-tetrahydropyrans
AT338423B (de) Verfahren zur herstellung von neuen 1,2,4-dithiaaz-3-enen
ATA404877A (de) Verfahren zur herstellung des neuen 9-formyl-9,10-dihydro-9,10-methanoanthracens

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties